文献速递前列腺增生与排尿功能障碍泌尿系感染

无症状尿检阳性患者膀胱内注射A型肉毒毒素的安全性

Safety of Intradetrusor OnabotulinumtoxinA (BTX-A) Injection in the Asymptomatic Patient With a Positive Urine Dip.
PubMed 文献 · Urology · 2019-10-07

该单中心回顾性研究纳入2016–2018年335个膀胱内BTX-A注射周期,比较无症状尿检阳性与阴性患者的不良事件差异。结论不支持对无症状患者术前常规行尿检。

要点

  • 无症状尿检阳性患者注射BTX-A后不良事件率与阴性者无显著差异。
  • 总体不良事件率14.6%,最常见为尿路感染(9%),其次尿潴留(3%)。
  • 7种尿检阳性定义下均未发现阳性与阴性组间差异,不支持术前常规尿检。

核心结论

  • 数据不支持对接受膀胱内BTX-A注射的无症状患者术前常规行尿检,因结果无法预测结局或不良事件。

研究设计与样本

  • 单中心回顾性研究,2016–2018年共212例患者、335个膀胱内BTX-A注射周期,平均年龄65岁(范围21–90)。
  • 排除留置导尿管、近期尿培养阳性、近期使用抗生素或注射当日无尿检者;采用7种不同组合的尿检阳性定义进行比较。

主要发现

  • 总体不良事件率14.6%,尿路感染率9%,尿潴留率3%。
  • 所有组中最常见不良事件为尿路感染,其次为尿潴留,无Clavien-Dindo定义的重大并发症。

关键数值与推荐

  • 73%患者接受100单位BTX-A,73%为非神经源性诊断。
  • 尿检阳性定义为血、白细胞酯酶或亚硝酸盐任意水平阳性的7种不同组合。

临床怎么用

  • 对无症状患者行膀胱内BTX-A注射前,可考虑不常规行尿检,因尿检结果未能预测不良事件。

局限性

  • 单中心回顾性设计,样本来自单一机构,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate differences in adverse events (AE) in asymptomatic patients with a positive urine dip (UD) at time of intradetrusor onabotulinumtoxinA (BTX-A) injection vsthose with a defined negative UD. MATERIALS AND METHODS: All intradetrusor BTX-A injections were retrospectively reviewed at a single institution between 2016 and 2018. Exclusion criteria included an indwelling catheter, recent positive urine culture, recent antibiotic course, or absence of UD on the day of injection. A positive UD was defined using 7 different definitions with varying combinations of any level of positive blood, leukocyte esterase, or nitrite. Negative UDs were defined those excluded from the positive UD group. We compared multiple positive UD-defined groups to their respective negative UD cohorts with regards to outcomes and demographics. RESULTS: A total of 212 patients underwent 335 cycles of BTX-A injections over a 2-year period. The average age was 65 years (range: 21-90). The majority received 100 units (73%) of BTX-A for a non-neurogenic diagnosis (73%). The overall rate of AEs, urinary tract infection, and urinary retention was 14.6%, 9%, and 3%, respectively. In all groups, the most common AE was urinary tract infection followed by urinary retention. There were no major Clavien-Dindo-defined complications. There was no statistically significant difference in the total or categorical AE rates between positive and negative UD groups using all 7 definitions of a positive UD (P = .05-1.0). CONCLUSION: These data do not support the practice of obtaining a preprocedure UD in asymptomatic patients undergoing intradetrusor BTX-A injection for any indication; test results are unable to predict outcomes or AEs.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Derisavifard S, Giusto LL, Zahner P, et al. Safety of Intradetrusor OnabotulinumtoxinA (BTX-A) Injection in the Asymptomatic Patient With a Positive Urine Dip. Urology. 2019. PMID: 31600558. doi:10.1016/j.urology.2019.09.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。